Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

2.27
BATS BZX Real-Time Price
As of 11:23am ET
 +0.07 / +3.18%
Today’s Change
2.05
Today|||52-Week Range
4.80
-1.30%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.20
Today’s open2.26
Day’s range2.24 - 2.27
Volume1,101
Average volume (3 months)91,806
Market cap$24.4M
Dividend yield--
Data as of 11:23am ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)+6.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.64%
P/E ratioNM
Price/Sales1.59
Price/Book0.54

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...-0.02-2.40%
IMNPImmune Pharmaceutica...+0.01+7.41%
ABIOARCA Biopharma Inc-0.05-1.96%
EYEGEyeGate Pharmaceutic...-0.06-2.40%
Data as of 11:26am ET, 03/29/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$14.5M
Annual profit (last year)-$9.0M
Net profit margin-61.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs